Association of a Leu10 → Pro polymorphism of the transforming growth factor-β1 with genetic susceptibility to osteoporosis and spinal osteoarthritis

Mechanisms of Ageing and Development

Volumn 116, Issue 2-3, 2000, Pages 113-123

  Yamada, Yoshiji ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Bone mineral density; Osteoarthritis; Osteoporosis; Polymorphism; Postmenopausal women; Transforming growth factor 1

Indexed keywords

LEUCINE; PROLINE; TRANSFORMING GROWTH FACTOR BETA1; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

AMINO ACID SUBSTITUTION; BONE DENSITY; BONE MASS; BONE REMODELING; CONFERENCE PAPER; ENVIRONMENTAL FACTOR; GENE LOCATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN TISSUE; OSTEOARTHRITIS; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; SPINE DISEASE; ANIMAL; ARTICLE; BLOOD; DISEASE PREDISPOSITION; GENETIC PREDISPOSITION; GENETICS; OSTEOPOROSIS; RADIUS; TREATMENT OUTCOME;

ANIMALS; BONE DENSITY; DISEASE SUSCEPTIBILITY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LEUCINE; OSTEOARTHRITIS; OSTEOPOROSIS; POLYMORPHISM, GENETIC; PROLINE; RADIUS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TREATMENT OUTCOME;

EID: 0034738172     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(00)00131-7     Document Type: Conference Paper

References (55)

1. Annunen S., Paassilta P., Lohiniva J., Perälä M., Pihlajamaa T., Karppinen J., Tervonen O., Kröger H., Lähde S., Vanharanta H., Ryhänen L., Göring H.H.H., Ott J., Prockop D.J., Ala-Kokko L. An allele of COL9A2 associated with intervertebral disc disease. Science. 285:1999;409-412.
2. Bonewald L.F. Transforming growth factor-β Bilezikian J.P., Raisz L.G., Rodan G.A. Principles of Bone Biology. 1996;647-659 Academic Press, San Diego.
3. Cambien F., Ricard S., Troesch A., Mallet C., Générénaz L., Evans A., Arveiler D., Luc G., Ruidavets J.-B., Poirier O. Polymorphism of the transforming growth factor-β1 gene in relation to myocardial infarction and blood pressure. Hypertension. 28:1996;881-887.
4. Creamer P., Hochberg M.C. Osteoarthritis. Lancet. 350:1997;503-509.
5. Dequeker J., Mohan S., Finkelman R.D., Aerssens J., Baylink D.J. Generalized osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor β in cortical bone from the iliac crest: possible mechanism of increased bone density and protection against osteoporosis. Arthritis Rheum. 36:1993;1702-1708.
6. Derynck R., Jarrett J.A., Chen E.Y., Eaton D.H., Bell J.R., Assoian R.K., Roberts A.B., Sporn M.B., Goeddel D.V. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature. 316:1985;701-705.
7. Derynck R., Rhee L., Chen E.Y., Tilburg A.V. Intron-exon structure of the human transforming growth factor-β precursor gene. Nucleic Acids Res. 15:1987;3188-3189.
8. Felson D.T., Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum. 41:1998;1343-1355.
9. Finkelman R.D., Linkhart T.A., Mohan S., Lau K.-H.W., Baylink D.J., Bell N.H. Vitamin D deficiency causes a selective reduction in deposition of transforming growth factor β in rat bone: possible mechanism for impaired osteoinduction. Proc. Natl. Acad. Sci. USA. 88:1991;3657-3660.
10. Finkelman R.D., Bell N.H., Strong D.D., Demers L.M., Baylink D.J. Ovariectomy selectively reduces the concentration of transforming growth factor β in rat bone: implications for estrogen deficiency-associated bone loss. Proc. Natl. Acad. Sci. USA. 89:1992;12190-12193.
11. Geiser A.G., Zeng Q.Q., Sato M., Helvering L.M., Hirano T., Turner C.H. Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-β1 gene. Bone. 23:1998;87-93.
12. Grainger D.J., Heathcote K., Chiano M., Snieder H., Kemp P.R., Metcalfe J.C., Carter N.D., Spectror T.D. Genetic control of the circulating concentration of transforming growth factor β1. Hum. Mol. Genet. 8:1999;93-99.
13. Grant S.F.A., Reid D.M., Blake G., Herd R., Fogelman I., Ralston S.H. Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type Iα1 gene. Nat. Genet. 14:1996;203-205.
14. Gueguen R., Jouanny P., Guillemin F., Kuntz C., Pourel J., Siest G. Segregation analysis and variance components analysis of bone mineral density in healthy families. J. Bone Miner. Res. 12:1995;2017-2022.
15. Günther M., Haubeck H.-D., van de Leur E., Bläser J., Bender S., Gütgemann I., Fischer D.-C., Tschesche H., Greiling H., Heinrich P.C., Graeve L. Transforming growth factor β1 regulates tissue inhibitor of metalloproteinases-1 expression in differentiated human articular chondrocytes. Arthritis Rheum. 37:1994;395-405.
16. Hamerman D. Aging and osteoarthritis: basic mechanisms. J. Am. Geriatr. Soc. 41:1993;760-770.
17. Hamerman D., Stanley E.R. Implications of increased bone density in osteoarthritis. J. Bone Miner. Res. 11:1996;1205-1208.
18. Harada A., Okuizumi H., Miyagi N., Genda E. Correlation between bone mineral density and intervertebral disc degeneration. Spine. 23:1998;857-862.
19. Harris S.S., Eccleshall T.R., Gross C., Dawson-Hughes B., Feldman D. The vitamin D receptor start codon polymorphism (Fok I) and bone mineral density in premenopausal American black and white women. J. Bone Miner. Res. 12:1997;1043-1048.
20. Hart D.J., Mootoosamy I., Doyle D.V., Spector T.D. The relationship between osteoarthritis and osteoporosis in the general population: the Chingford study. Ann. Rheum. Dis. 53:1994;158-162.
21. Hirsch R., Lethbridge-Cejku M., Hanson R., Scott W.W. Jr, Reichle R., Plato C.C., Tobin J.D., Hochberg M.C. Familial aggregation of osteoarthritis: data from the Baltimore longitudinal study on aging. Arthritis Rheum. 41:1998;1227-1232.
22. Hughes D.E., Dai A., Tiffee J.C., Li H.H., Mundy G.R., Boyce B.F. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β Nat. Med. 2:1996;1132-1136.
23. Kanis J.A., Melton L.J. Jr, Christiansen C., Johnston C.C., Khaltaev N. The diagnosis of osteoporosis. J. Bone Miner. Res. 9:1994;1137-1141.
24. Karvonen M.K., Pesonen U., Koulu M., Niskanen L., Laakso M., Rissanen A., Dekker J.M., 't Hart L.M., Valve R., Uusitupa M.I.J. Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels. Nat. Med. 4:1998;1434-1437.
25. Knowlton R.G., Katzenstein P.L., Moskowitz R.W., Weaver E.J., Malemud C.J., Pathria M.N., Jimenez S.A., Prockop D.J. Genetic linkage of a polymorphism in the type II procollagen gene (COL2A1) to primary osteoarthritis associated with mild chondrodysplasia. New Engl. J. Med. 322:1990;526-530.
26. Kobayashi S., Inoue S., Hosoi T., Ouchi Y., Shiraki M., Orimo H. Association of bone mineral density with polymorphism of the estrogen receptor gene. J. Bone Miner. Res. 11:1996;306-311.
27. Langdahl B.L., Knudsen J.Y., Jensen H.K., Gregersen N., Eriksen E.F. A sequence variation: 713-8delC in the transforming growth factor-β1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women. Bone. 20:1997;289-294.
28. Mansell J.P., Bailey A.J. Abnormal cancellous bone collagen metabolism in osteoarthritis. J. Clin. Invest. 101:1998;1596-1603.
29. Morrison N.A., Qi J.C., Tokita A., Kelly P.J., Crofts L., Nguyen T.V., Sambrook P.N., Eisman J.A. Prediction of bone density from vitamin D receptor alleles. Nature. 367:1994;284-287.
30. Nathan H. Osteophytes of the vertebral column: an anatomical study of their development according to age, race, and sex with considerations as to their etiology and significance. J. Bone Jt. Surg. 44A:1962;243-268.
31. Nicolas V., Prewett A., Bettica P., Mohan S., Finkelman R.D., Baylink D.J., Farley J.R. Age-related decreases in insulin-like growth factor-I and transforming growth factor-β in femoral cortical bone from both men and women: implications for bone loss with aging. J. Clin. Endocrinol. Metab. 78:1994;1011-1016.
32. Noda M., Camilliere J.J. In vivo stimulation of bone formation by transforming growth factor-β Endocrinology. 124:1989;2991-2994.
33. Orimo H., Sugioka Y., Fukunaga M., Muto Y., Hotokebuchi T., Gorai I., Nakamura T., Kushida K., Tanaka H., Ikai T., Oh-hashi Y. Diagnosis criteria of primary osteoporosis. J. Bone Miner. Metab. 16:1998;139-150.
34. Oursler M.J. Osteoclast synthesis and secretion and activation of latent transforming growth factor-β J. Bone Miner. Res. 9:1994;443-452.
35. Oursler M.J., Cortese C., Keeting P., Anderson M.A., Bonde S.K., Riggs B.L., Spelsberg T.C. Modulation of transforming growth factor-β production in normal human osteoblast-like cells by 17β-estradiol and parathyroid hormone. Endocrinology. 129:1991;3313-3320.
36. Pfeilschifter J., Seyedin S.M., Mundy G.R. Transforming growth factor β inhibits bone resorption in fetal rat long bone cultures. J. Clin. Invest. 82:1988;680-685.
37. Pocock N.A., Eisman J.A., Hopper J.L., Yeates M.G., Sambrook P.N., Eberl S. Genetic determinants of bone mass in adults: a twin study. J. Clin. Invest. 80:1987;706-710.
38. Sambrook P.N., MacGregor A.J., Spector T.D. Genetic influences on cervical and lumbar disc degeneration: a magnetic resonance imaging study in twins. Arthritis Rheum. 42:1999;366-372.
39. Shiraki M., Shiraki Y., Aoki C., Hosoi T., Inoue S., Kaneki M., Ouchi Y. Association of bone mineral density with apolipoprotein E phenotype. J. Bone Miner. Res. 12:1997;1438-1445.
40. Slemenda C.W., Christian J.C., Williams C.J., Norton J.A., Johnston C.C. Jr Genetic determinants of bone mass in adult women: a reevaluation of the twin model and the potential importance of gene interaction on heritability estimates. J. Bone Miner. Res. 6:1991;561-567.
41. Spector T.D., Cicuttini F., Baker J., Loughlin J., Hart D. Genetic influence on osteoarthritis in women: a twin study. Br. Med. J. 312:1996;940-944.
42. 3-mediated transforming growth factor-β release is impaired in cultured osteoblasts from patients with multiple pituitary hormone deficiencies. J. Bone Miner. Res. 11:1996;367-376.
43. Takai H., Kanematsu M., Yano K., Tsuda E., Higashio K., Ikeda K., Watanabe K., Yamada Y. Transforming growth factor-β stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow cells. J. Biol. Chem. 273:1998;27091-27096.
44. Uitterlinden A.G., Burger H., Huang Q., Odding E., van Duijn C.M., Hofman A., Birkenhäger J.C., van Leeuwen J.P.T.M., Pols H.A.P. Vitamin D receptor genotype is associated with radiographic osteoarthritis at the knee. J. Clin. Invest. 100:1997;259-263.
45. Uitterlinden A.G., Burger H., Huang Q., Yue F., McGuigan F.E.A., Grant S.F.A., Hofman A., van Leeuwen J.P.T.M., Pols H.A.P., Ralston S.H. Relation of alleles of the collagen type Iα1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. New Engl. J. Med. 338:1998;1016-1021.
46. van Beuningen H.M., van der Kraan P.M., Arntz O.J., van den Berg W.B. Transforming growth factor-β1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab. Invest. 71:1994;279-290.
47. Verner K., Schatz G. Protein translocation across membranes. Science. 241:1988;1307-1313.
48. Videman T., Leppävuori J., Kaprio J., Battié M.C., Gibbons L.E., Peltonen L., Koskenvuo M. Intragenic polymorphisms of the vitamin D receptor gene associated with intervertebral disc degeneration. Spine. 23:1998;2477-2485.
49. Vikkula M., Mariman E.C.M., Lui V.C.H., Zhidkova N.I., Tiller G.E., Goldring M.B., van Beersum S.E.C., de Waal Malefijt M.C., van den Hoogen F.H.J., Ropers H.-H., Mayne R., Chean K.S.E., Olsen B.R., Warman M.L., Brunner H.G. Autosomal dominant and recessive osteochondrodysplasia associated with the COL11A2 locus. Cell. 80:1995;431-437.
50. Villiger P.M., Lotz M. Differential expression of TGFβ isoforms by human articular chondrocytes in response to growth factors. J. Cell. Physiol. 151:1992;318-325.
51. Yamada Y., Miyauchi A., Goto J., Takagi Y., Okuizumi H., Kanematsu M., Hase M., Takai H., Harada A., Ikeda K. Association of a polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to osteoporosis in Japanese women. J. Bone Miner. Res. 13:1998;1569-1576.
52. Yamada Y., Hosoi T., Makimoto F., Tanaka H., Seino Y., Ikeda K. Transforming growth factor β-1 gene polymorphism and bone mineral density in Japanese adolescents. Am. J. Med. 106:1999;477-479.
53. Yamada, Y., Okuizumi, H., Miyauchi, A., Takagi, Y., Ikeda, K., Harada, A., 2000a. Association of transforming growth factor β1 genotype with spinal osteophytosis in Japanese women. Arthritis Rheum. 43, 452-460.
54. Yamada, Y., Harada, A., Hosoi, T., Miyauchi, A., Ikeda, K., Ohta, H., Shiraki, M., 2000b. Association of transforming growth factor β1 genotype with therapeutic response to active vitamin D for postmenopausal osteoporosis. J. Bone Miner. Res. 15, 415-420.
55. Yanagisawa J., Yanagi Y., Masuhiro Y., Suzawa M., Watanabe M., Kashiwagi K., Toriyabe T., Kawabata M., Miyazono K., Kato S. Convergence of transforming growth factor-β and vitamin D signaling pathways on SMAD transcriptional coactivators. Science. 283:1999;1317-1321.